Expert Witness Journal Issue 68 August 2026 - Flipbook - Page 116
Delayed Referral in Suspected Cancer: A
GP Expert Witness Perspective on Breach,
Causation, and Missed Opportunity
by Dr Samah Boulis, GP Expert Witness.
(notably NG12), which provides symptom-based
thresholds for urgent referral.
Abstract
Delayed referral for suspected cancer remains one
of the most litigated and clinically signi昀椀cant areas
in primary care negligence. For clinical negligence
solicitors, these cases sit at the intersection of
evolving guidelines, diagnostic uncertainty, and
the realities of time-pressured consultations. This
article examines how delayed referral claims arise,
how they are analysed from an expert witness
standpoint, and where the strongest—and weakest—
cases tend to lie.
However, since October 2023, the NHS has reformed
cancer waiting time standards, replacing the Two
Week Wait target with the Faster Diagnosis Standard
(FDS). This standard requires that patients referred
with suspected cancer receive a diagnosis—or have
cancer ruled out—within 28 days of referral. The
emphasis has therefore shifted from speed of 昀椀rst
specialist assessment to timeliness of diagnostic
resolution.
Why Delayed Referral Cases Matter
Urgent suspected cancer referrals (still commonly
referred to as “2WW”) remain in clinical use and
continue to be guided by NG12 criteria. However,
they now function within a broader diagnostic
pathway that prioritises rapid investigation, often
through straight-to-test models, rather than an
initial outpatient appointment.
Timeliness is a critical determinant of cancer
outcomes. Even relatively short delays in referral
can result in disease progression from a potentially
curable stage to one where treatment is palliative.
In medico-legal terms, delayed referral cases are
often compelling because they present a structured
framework for analysis:
•
Established national guidance
thresholds for urgent action
•
Discrete and identi昀椀able clinical decision points
within primary care
•
Potentially quanti昀椀able harm in terms of stage
migration, treatment burden, and prognosis
From a medico-legal perspective, the FDS does not
alter the legal test for negligence, which continues to
be determined by established principles of reasonable
clinical practice. However, it is increasingly relevant
as contextual evidence of expected timeliness within
the NHS. In particular, it reinforces the importance
of prompt referral decisions in primary care, as any
delay may postpone entry into a pathway designed to
deliver diagnosis within 28 days.
de昀椀ning
Yet they are rarely straightforward. General practice
operates in a setting of low prevalence and high
uncertainty—most symptoms that could indicate
cancer do not. Clinical decision-making must
therefore balance the risks of over-investigation
against the consequences of missed or delayed
diagnosis.
These pathways frequently form the benchmark
against which GP conduct is judged—but crucially,
they operate within, not instead of, established legal
tests for negligence.
The Legal Framework: Bolam and
Bolitho in Practice
Central to this framework in England has
traditionally been the Two Week Wait (2WW)
referral pathway, ensuring patients with suspected
cancer are seen by a specialist within two weeks.
These pathways are grounded in guidance from the
National Institute for Health and Care Excellence
EXPERT WITNESS JOURNAL
In determining breach of duty, the court relies
on principles that are both longstanding and
highly relevant to modern general practice.
The foundations lie in Bolam v Friern Hospital
114
AUGUST 2026